To understand physician preferences and bleeding complication rates of
intramuscular botulinum neurotoxin type A injections for spasticity
management in anticoagulated patients, questionnaires were mailed to 138
physicians across Canada. The international normalized ratio comfort range
for injections was <2.0 in 10%, 2.0 to 2.5 in 35%, 2.6 to 3.0 in 25%, and
3.1 to 3.5 in 20% of physicians. Only 23% injected outside their comfort
value and 57% did not; 72% did not normalize the international normalized
ratio value before injections. Only one injector reported the development of
compartment syndrome. As expected, high variability exists in physician
preferences in botulinum neurotoxin type A injection in anticoagulated
patients.